Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert D Inman

Showing results (221-230 of 258) with videos related to

Pageof 26
Sort By:
The Journal of Clinical Investigation|March 10, 2020
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritisEric Gracey, Dominika Hromadová, Melissa Lim, et al.
Annals of the Rheumatic Diseases|March 16, 2011
Predicting the outcome of ankylosing spondylitis therapyNathan Vastesaeger, Désirée van der Heijde, Robert D Inman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 24, 2022
Platelet-Derived Growth Factor B Is a Key Element in the Pathological Bone Formation of Ankylosing SpondylitisSungsin Jo, Seung Hoon Lee, Jinsung Park, et al.
The Journal of Rheumatology|December 1, 2022
Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial SpondyloarthritisRobert D Inman, Marco Garrido-Cumbrera, Jonathan Chan, et al.
Communications Biology|September 21, 2022
A Hidden Markov Model reveals magnetoencephalography spectral frequency-specific abnormalities of brain state power and phase-coupling in neuropathic painCamille Fauchon, Junseok A Kim, Rima El-Sayed, et al.
The Journal of Rheumatology|February 17, 2015
2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management RecommendationsSherry Rohekar, Jon Chan, Shirley M L Tse, et al.
The Journal of Rheumatology|February 17, 2015
2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in CanadaSherry Rohekar, Jon Chan, Shirley M L Tse, et al.
Pain|October 29, 2021
Exploring sex differences in alpha brain activity as a potential neuromarker associated with neuropathic painCamille Fauchon, Junseok A Kim, Rima El-Sayed, et al.
Musculoskeletal Care|December 10, 2024
Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS)Proton Rahman, Marco Garrido-Cumbrera, Sherry Rohekar, et al.
Lancet (London, England)|July 3, 2018
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind studyRobert Landewé, Joachim Sieper, Philip Mease, et al.
Pageof 26

Showing results (221-230 of 258) with videos related to

Sort By:
Pageof 26
The Journal of Clinical Investigation|March 10, 2020
TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritisEric Gracey, Dominika Hromadová, Melissa Lim, et al.
Annals of the Rheumatic Diseases|March 16, 2011
Predicting the outcome of ankylosing spondylitis therapyNathan Vastesaeger, Désirée van der Heijde, Robert D Inman, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|November 24, 2022
Platelet-Derived Growth Factor B Is a Key Element in the Pathological Bone Formation of Ankylosing SpondylitisSungsin Jo, Seung Hoon Lee, Jinsung Park, et al.
The Journal of Rheumatology|December 1, 2022
Work-Related Issues and Physical and Psychological Burden in Canadian Patients With Axial Spondyloarthritis: Results From the International Map of Axial SpondyloarthritisRobert D Inman, Marco Garrido-Cumbrera, Jonathan Chan, et al.
Communications Biology|September 21, 2022
A Hidden Markov Model reveals magnetoencephalography spectral frequency-specific abnormalities of brain state power and phase-coupling in neuropathic painCamille Fauchon, Junseok A Kim, Rima El-Sayed, et al.
The Journal of Rheumatology|February 17, 2015
2014 Update of the Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Treatment Recommendations for the Management of Spondyloarthritis. Part II: Specific Management RecommendationsSherry Rohekar, Jon Chan, Shirley M L Tse, et al.
The Journal of Rheumatology|February 17, 2015
2014 Update of the Canadian Rheumatology Association/spondyloarthritis research consortium of Canada treatment recommendations for the management of spondyloarthritis. Part I: principles of the management of spondyloarthritis in CanadaSherry Rohekar, Jon Chan, Shirley M L Tse, et al.
Pain|October 29, 2021
Exploring sex differences in alpha brain activity as a potential neuromarker associated with neuropathic painCamille Fauchon, Junseok A Kim, Rima El-Sayed, et al.
Musculoskeletal Care|December 10, 2024
Canadian Patients With Axial Spondyloarthritis Require Almost a Decade To Be Diagnosed Leading to Severe Functional Limitation. Results From the International Map of Axial Spondyloarthritis (IMAS)Proton Rahman, Marco Garrido-Cumbrera, Sherry Rohekar, et al.
Lancet (London, England)|July 3, 2018
Efficacy and safety of continuing versus withdrawing adalimumab therapy in maintaining remission in patients with non-radiographic axial spondyloarthritis (ABILITY-3): a multicentre, randomised, double-blind studyRobert Landewé, Joachim Sieper, Philip Mease, et al.
Pageof 26